Home › Therapeutic areas › Ophthalmology › Wet AMD

Wet AMD (6 companies)

Companies with an active program in Wet AMD.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
FDMT 4D Molecular Therapeutics OphthalmologyRespiratory Rare 1 Phase 3 $608M 5
HROW Harrow Ophthalmology Rare 2 Approved $1.11B 15
KOD Kodiak Sciences Ophthalmology 2 Phase 3 $6.33B 8
NBP NovaBridge Biosciences OncologyOphthalmology 1 Phase 2 $95.4M 7
OCGN Ocugen Infectious DiseaseOphthalmology Rare 1 Phase 3 $257M 12
OTLK Outlook Therapeutics Ophthalmology 1 Approved $87.9M 3